Regeneron Acquires 23andMe for $256 Million
Regeneron Pharmaceuticals, a leading biotechnology company, has announced its acquisition of 23andMe for $256 million. 2...
Isomorphic Labs, Google's AI Drug Discovery Firm, Secures Fu...
Isomorphic Labs, a company owned by Google's parent Alphabet, is using artificial intelligence to revolutionize drug dis...
AI-Powered Drug Discovery Saves Man's Life After Doctors' Di...
A man facing a life-threatening illness was given little hope by doctors. However, scientists turned to artificial intel...
AI Repurposes Existing Drugs, Potentially Saving Lives
Artificial intelligence is being used to identify new uses for existing medications, offering hope for patients with dif...
AI Uncovers Hidden Uses for Existing Drugs
Scientists are employing artificial intelligence to explore new therapeutic possibilities within a vast library of alrea...